--- title: "SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LIMITED — Ownership Dossier" canonical: https://whiteintel.dev/entity/f361479b-91eb-52d6-babb-bfae92ae1b57 json: https://whiteintel.dev/api/public/dossier/f361479b-91eb-52d6-babb-bfae92ae1b57 identifier: oo:GB-COH-09389074 jurisdiction: GB risk: Low source: WhiteIntel corporate-ownership graph --- # SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LIMITED **Type:** Company **Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb) **Identifier:** `oo:GB-COH-09389074` **Risk level:** Low **Canonical dossier:** https://whiteintel.dev/entity/f361479b-91eb-52d6-babb-bfae92ae1b57 **Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/f361479b-91eb-52d6-babb-bfae92ae1b57 ## Cross-source identity The same real-world entity, resolved across sources: - **SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LIMITED** — GLEIF · `lei:213800YX6XAGBI67FL81` — https://whiteintel.dev/entity/95983501-7f89-5467-a26e-af9ed657bf30 ## Ownership & control ### Owners / controllers - **SYNEXUS CLINICAL RESEARCH TOPCO LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/2351b5d9-a469-52c6-81a5-55574c4a5806 - **PPD INTERNATIONAL INVESTMENTS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/369e8f11-3f32-51cc-ab0b-856b2c1ab4a9 - **PPD INTERNATIONAL INVESTMENTS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/369e8f11-3f32-51cc-ab0b-856b2c1ab4a9 - **SYNEXUS CLINICAL RESEARCH TOPCO LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/2351b5d9-a469-52c6-81a5-55574c4a5806 ### Holdings / subsidiaries - **SYNEXUS CLINICAL RESEARCH LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/651df19c-f106-56f8-9286-0a221289255d - **SYNEXUS CLINICAL RESEARCH ACQUISITIONS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/d0494c05-c123-5c41-b4a7-fe27396f3b30 - **SYNEXUS CLINICAL RESEARCH ACQUISITIONS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/d0494c05-c123-5c41-b4a7-fe27396f3b30 - **SYNEXUS CLINICAL RESEARCH LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/651df19c-f106-56f8-9286-0a221289255d - **Synexus Clinical Research Midco No 2 Limited** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/16adb898-309c-460e-87e5-84fbd2fc8730 ### UBO chain (walk to the ultimate owner) A **18-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing. ## Company profile (live · UK Companies House) - **Company number:** `09389074` - **Status:** active - **Type:** ltd - **Incorporated:** 2015-01-14 - **Registered office:** 12b Granta Park Great Abington, Cambridge, CB21 6GQ, England - **SIC:** 74909 ### Officers - [OAKWOOD CORPORATE SECRETARY LIMITED](https://whiteintel.dev/entity/1c359d14-ce8b-42da-aba0-13fad1c329e5) — corporate secretary · appointed 2022-11-29 - AHMED, Syed Waqas — director · British · appointed 2023-03-29 - CAMERON, Euan Daney Ross — director · British · appointed 2023-03-29 - GREEN, Georgina Adams — director · British · appointed 2024-04-18 - SMITH, Anthony Hugh — director · American · appointed 2023-03-29 - STARR, Alison Jane — director · British · appointed 2024-04-18 - GREGG, Rhona — secretary · appointed 2022-11-29 · resigned 2026-03-31 - BERTHOUX, Christophe — director · French · appointed 2015-01-14 · resigned 2016-05-31 - CHAMBERS, Paul Michael — director · British · appointed 2016-01-01 · resigned 2016-05-31 - EVANS, Hywel — director · British · appointed 2015-02-18 · resigned 2016-05-31 - HARRIS, Richard Stuart — director · British · appointed 2021-06-30 · resigned 2023-03-29 - HARTMAN, Brainard Judd — director · American · appointed 2016-05-31 · resigned 2020-03-19 - JAMES, Julia Mary — director · British · appointed 2016-05-31 · resigned 2023-05-24 - NEILD, Christopher David — director · British · appointed 2016-05-31 · resigned 2020-03-19 - NORMAN, David John — director · British · appointed 2023-03-29 · resigned 2024-04-18 - TONDER, Riaan Van — director · South African · appointed 2020-03-13 · resigned 2021-06-30 ### Beneficial owners (Persons with Significant Control) - [Ppd International Investments Limited](https://whiteintel.dev/entity/369e8f11-3f32-51cc-ab0b-856b2c1ab4a9) — 75–100% shares · corporate PSC · United Kingdom — since 2016-11-17 - [Synexus Clinical Research Topco Limited](https://whiteintel.dev/entity/2351b5d9-a469-52c6-81a5-55574c4a5806) — 75–100% shares · corporate PSC · United Kingdom — ceased 2016-11-17 ## Provenance - OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/09389074 - companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/09389074 ## Get the full, resolved dossier (agent-callable) The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent: ```bash npx -y @whiteintel/mcp-server # then: get_dossier · trace_ownership_path · check_offshore_exposure ``` Or unlock a one-off cited dossier for **SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LIMITED** — https://whiteintel.dev/entity/f361479b-91eb-52d6-babb-bfae92ae1b57 · pricing https://whiteintel.dev/pricing. --- _This is the markdown-for-agents view of the WhiteIntel dossier for **SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LIMITED**. Human view: https://whiteintel.dev/entity/f361479b-91eb-52d6-babb-bfae92ae1b57 · Structured JSON: https://whiteintel.dev/api/public/dossier/f361479b-91eb-52d6-babb-bfae92ae1b57._ _Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._